Mechanism of action of bisphosphonates - PubMed (original) (raw)

Review

Mechanism of action of bisphosphonates

Alfred A Reszka et al. Curr Osteoporos Rep. 2003 Sep.

Abstract

In recent years, substantial progress has been made in understanding the mechanism for bisphosphonate suppression of bone turnover. Bisphosphonates can now be distinguished based on their molecular and cellular mechanisms of action. Simple bisphosphonates such as clodronate and etidronate inhibit bone resorption through induction of osteoclast apoptosis. Clodronate, and perhaps etidronate, triggers apoptosis by generating a toxic analog of adenosine triphosphate, which then targets the mitochondria, the energy center within the cell. For nitrogen-containing bisphosphonates, the direct intracellular target is the enzyme farnesyl diphosphate synthase in the cholesterol biosynthetic pathway. Its inhibition suppresses a process called protein geranylgeranylation, which is essential for the basic cellular processes required for osteoclastic bone resorption. Although nitrogen-containing bisphosphonates can induce osteoclast apoptosis, this is not necessary for their inhibition of bone resorption.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Cell Sci. 1995 Jun;108 ( Pt 6):2285-92 - PubMed
    1. Curr Rheumatol Rep. 2003 Feb;5(1):65-74 - PubMed
    1. J Bone Miner Res. 2000 Aug;15(8):1467-76 - PubMed
    1. J Bone Miner Res. 1998 Nov;13(11):1668-78 - PubMed
    1. J Bone Miner Res. 1994 Dec;9(12):1875-82 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources